Literature DB >> 24549105

White matter changes associated with antipsychotic treatment in first-episode psychosis.

Philip R Szeszko1, Delbert G Robinson1, Toshikazu Ikuta2, Bart D Peters3, Juan A Gallego1, John Kane1, Anil K Malhotra1.   

Abstract

Second-generation antipsychotics are utilized extensively in the treatment of psychotic disorders and other psychiatric conditions, but the effects of these medications on human brain white matter are not well understood. We thus investigated the effects of second-generation antipsychotics on white matter integrity using tract-based spatial statistics in patients experiencing a first episode of psychosis with little or no prior antipsychotic exposure, and how potential changes were associated with metabolic side effects. Thirty-five (26 men/9 women) patients experiencing a first episode of psychosis received diffusion tensor imaging (DTI) exams, clinical assessments, and provided fasting blood samples at the onset of antipsychotic treatment, and then again after 12 weeks of treatment with either risperidone or aripiprazole in a double-blind randomized clinical trial. In addition, 35 (26 men/9 women) healthy volunteers received DTI exams at a baseline time point and then after 12 weeks. Patients demonstrated significant (p<0.05; family-wise error corrected) fractional anisotropy reductions within the parietal and occipital white matter following antipsychotic treatment. Greater overall fractional anisotropy reduction was significantly correlated with greater increases in low-density lipoprotein. There were no significant fractional anisotropy increases among patients following treatment. Moreover, healthy volunteers did not demonstrate either significant increases or decreases in fractional anisotropy across a comparable 12-week interval. The use of antipsychotics may be associated with a subtle loss of white matter integrity that is related to greater side effects, thus raising potentially important considerations regarding risk/benefit in their usage. Limitations of the current study, however, include a prior history of substance use among patients and our inability to exclude the possibility of disease progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24549105      PMCID: PMC3988536          DOI: 10.1038/npp.2013.288

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  51 in total

1.  The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.

Authors:  Karl-Anton Dorph-Petersen; Joseph N Pierri; James M Perel; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

2.  Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia.

Authors:  Vicente Molina; Santiago Reig; Javier Sanz; Tomás Palomo; Carlos Benito; Javier Sánchez; Fernando Sarramea; Javier Pascau; Manuel Desco
Journal:  Schizophr Res       Date:  2005-09-16       Impact factor: 4.939

3.  Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan.

Authors:  Tiao-Lai Huang; Jung-Fu Chen
Journal:  Schizophr Res       Date:  2005-06-17       Impact factor: 4.939

4.  Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study.

Authors:  Ragy R Girgis; Vaibhav A Diwadkar; Jeffrey J Nutche; John A Sweeney; Matcheri S Keshavan; Antonio Y Hardan
Journal:  Schizophr Res       Date:  2006-01-18       Impact factor: 4.939

5.  Demyelination increases radial diffusivity in corpus callosum of mouse brain.

Authors:  Sheng-Kwei Song; Jun Yoshino; Tuan Q Le; Shiow-Jiuan Lin; Shu-Wei Sun; Anne H Cross; Regina C Armstrong
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

Review 6.  The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?

Authors:  Chris Bushe; Carol Paton
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

7.  Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.

Authors:  Delbert G Robinson; Margaret G Woerner; Barbara Napolitano; Raman C Patel; Serge M Sevy; Handan Gunduz-Bruce; Jose M Soto-Perello; Alan Mendelowitz; Ali Khadivi; Rachel Miller; Joanne McCormack; Beth S Lorell; Martin L Lesser; Nina R Schooler; John M Kane
Journal:  Am J Psychiatry       Date:  2006-12       Impact factor: 18.112

8.  Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Authors:  Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

9.  A diffusion tensor magnetic resonance imaging study of frontal cortex connections in very-late-onset schizophrenia-like psychosis.

Authors:  Derek K Jones; Marco Catani; Carlo Pierpaoli; Suzanne J Reeves; Sukhwinder S Shergill; Michael O'Sullivan; Philip Maguire; Mark A Horsfield; Andrew Simmons; Steven C R Williams; Robert J Howard
Journal:  Am J Geriatr Psychiatry       Date:  2005-12       Impact factor: 4.105

10.  Probabilistic diffusion tractography with multiple fibre orientations: What can we gain?

Authors:  T E J Behrens; H Johansen Berg; S Jbabdi; M F S Rushworth; M W Woolrich
Journal:  Neuroimage       Date:  2006-10-27       Impact factor: 6.556

View more
  47 in total

1.  A Dissociation in Effects of Risperidone Monotherapy on Functional and Anatomical Connectivity Within the Default Mode Network.

Authors:  Xiaofen Zong; Maolin Hu; Spiro P Pantazatos; J John Mann; Gaohua Wang; Yanhui Liao; Zhong-Chun Liu; Wei Liao; Tao Yao; Zongchang Li; Ying He; Luxian Lv; Deen Sang; Jinsong Tang; Huafu Chen; Junjie Zheng; Xiaogang Chen
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 2.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

3.  White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.

Authors:  Wendy R Kates; Amy K Olszewski; Matthew H Gnirke; Zora Kikinis; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Petya D Radoeva; Frank A Middleton; Martha E Shenton; Ioana L Coman
Journal:  Schizophr Res       Date:  2014-07-25       Impact factor: 4.939

4.  Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial.

Authors:  Aristotle N Voineskos; Benoit H Mulsant; Erin W Dickie; Nicholas H Neufeld; Anthony J Rothschild; Ellen M Whyte; Barnett S Meyers; George S Alexopoulos; Matthew J Hoptman; Jason P Lerch; Alastair J Flint
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

5.  Psychosis risk is associated with decreased white matter integrity in limbic network corticostriatal tracts.

Authors:  Kelsey T Straub; Jessica P Y Hua; Nicole R Karcher; John G Kerns
Journal:  Psychiatry Res Neuroimaging       Date:  2020-05-15       Impact factor: 2.376

6.  Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.

Authors:  Nina Vanessa Kraguljac; David Matthew White; Nathan Hadley; Jennifer Ann Hadley; Lawrence Ver Hoef; Ebony Davis; Adrienne Carol Lahti
Journal:  Schizophr Bull       Date:  2016-02-12       Impact factor: 9.306

7.  Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study.

Authors:  Patrick Domen; Sanne Peeters; Stijn Michielse; Ed Gronenschild; Wolfgang Viechtbauer; Alard Roebroeck; Jim van Os; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

8.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

9.  Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.

Authors:  Bjørn H Ebdrup; Jayachandra M Raghava; Mette Ø Nielsen; Egill Rostrup; Birte Glenthøj
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

10.  Age and Sex Effects on White Matter Tracts in Psychosis from Adolescence through Middle Adulthood.

Authors:  Andrew Schwehm; Delbert G Robinson; Juan A Gallego; Katherine H Karlsgodt; Toshikazu Ikuta; Bart D Peters; Anil K Malhotra; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2016-04-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.